Adaptive Biotechnologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. 

CEO
Chad Robins
CEOChad Robins
Employees
624
Employees624
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2009
Founded2009
Employees
624
Employees624

ADPT Key Statistics

Market cap
3.61B
Market cap3.61B
Price-Earnings ratio
-68.78
Price-Earnings ratio-68.78
Dividend yield
Dividend yield
Average volume
2.74M
Average volume2.74M
High today
High today
Low today
Low today
Open price
$22.72
Open price$22.72
Volume
0.00
Volume0.00
52 Week high
$23.15
52 Week high$23.15
52 Week low
$9.96
52 Week low$9.96

Stock Snapshot

As of today, Adaptive Biotechnologies(ADPT) shares are valued at $22.07. The company's market cap stands at 3.61B, with a P/E ratio of -68.78.

During the trading day, Adaptive Biotechnologies(ADPT) stock saw an opening price of $22.72, a peak of —, and a bottom of —.

Trading volume for Adaptive Biotechnologies(ADPT) stock has reached 0, versus its average volume of 2.74M.

The stock's 52-week range extends from a low of $9.96 to a high of $23.15.

The stock's 52-week range extends from a low of $9.96 to a high of $23.15.

ADPT News

Simply Wall St 5d
How Raised MRD Revenue Guidance And Upgraded Earnings At Adaptive Biotechnologies Has Changed Its Investment Story

Earlier this week, Adaptive Biotechnologies was upgraded by analysts following upward revisions to earnings estimates, including an expected quarterly loss of U...

How Raised MRD Revenue Guidance And Upgraded Earnings At Adaptive Biotechnologies Has Changed Its Investment Story
Investing.com 5d
Adaptive Biotechnologies CSO Harlan Robins sells $10.78m in stock - Investing.com

...

Adaptive Biotechnologies CSO Harlan Robins sells $10.78m in stock - Investing.com

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.